Clinical trial
Evaluation of the Efficacy and Safety of an Eye Drops With Hydroxypropyl-methylcellulose and Inositol as Principal Components (MERAMIRT®) in the Treatment of Dry Eye Disease Associated to Asthenopia and Accommodative Effort in Video Display Terminal Users
NCT06190054 is registered in ClinicalTrials.gov with Fidia Farmaceutici s.p.a. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy and Safety of an Eye Drops With Hydroxypropyl-methylcellulose and Inositol as Principal Components (MERAMIRT®) in the Treatment of Dry Eye Disease Associated to Asthenopia and Accommodative Effort in Video Display Terminal Users
- Lead sponsor
- Fidia Farmaceutici s.p.a.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 6, 2023
- Completion date
- March 4, 2025
- Enrollment
- 100 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye disease associated to asthenopia and accommodative effort in video display terminal users